日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2 positive metastatic breast cancer: long term survival results from randomised phase 3 PHILA trial

吡咯替尼或安慰剂联合曲妥珠单抗和多西他赛治疗HER2阳性转移性乳腺癌:随机3期PHILA试验的长期生存结果

Ma, Fei; Yan, Min; Li, Wei; Ouyang, Quchang; Tong, Zhongsheng; Teng, Yuee; Wang, Yongsheng; Wang, Shusen; Geng, Cuizhi; Luo, Ting; Zhong, Jincai; Zhang, Qingyuan; Liu, Qiang; Zeng, Xiaohua; Sun, Tao; Mo, Qinguo; Zhou, Shoubing; Li, Peidong; Cheng, Jing; Wang, Xiaojia; Nie, Jianyun; Yang, Jin; Wu, Xinhong; Wang, Xinshuai; Li, Huiping; Yao, Guangyu; Fan, Yang; Lin, Jiaman; Zhu, Xiaoyu; Xu, Binghe

Expert consensus on the detection and clinical application of tumor mutational burden

关于肿瘤突变负荷的检测和临床应用的专家共识

Guo, Zhenying; Xu, Chunwei; Zhang, Shirong; Hao, Yue; Hu, Xiaotong; Zhao, Ming; Xiang, Chan; Piao, Yingshi; Sun, Pingli; Xiang, Xueping; Zhao, Jing; Wu, Huanwen; Li, Weixing; Yu, Jinpu; Yuan, Jingping; Wang, Shuangshuang; Wang, Cong; Gu, Yun; Lv, Bingjian; Zhang, Liping; Liu, Yueping; Cui, Xiaobin; Gu, Weizhong; Li, Yining; Wang, Wei; Yang, Wenjun; Long, Weiguo; Xiang, Jingjing; Mou, Hong; Liu, Biao; Ruan, Huajuan; Wang, Yubin; Zhu, Yongjie; Wang, Feng; Wang, Zhonghua; Feng, Xiaomin; Liu, Xing; Li, Peng; Deng, Min; Lian, Bin; Mao, Lili; Wang, Qian; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Zhong, Wenzhao; Wang, Zhijie; Ren, Shengxiang; Fang, Wenfeng; Zhang, Yongchang; Liu, Jingjing; Cai, Xiuyu; Liu, Anwen; Li, Wen; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Chen, Yu; Zhang, Yu; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Shen, Peng; Li, Xiaoyan; Tang, Chuanhao; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Guo, Hui; Chu, Qian; Meng, Rui; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Lu, Yuanyuan; Chen, Xiaofeng; Ge, Rui; Dai, Enyong; Han, Yu; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Liu, Xuewen; Yao, Yu; Luo, Peng; Pan, Weiwei; Pang, Fei; Wu, Fan; Gu, Dejian; Wang, Li; Wang, Liping; Zhu, Youcai; Lin, Li; Li, Weiwen; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Ji, Qing; Fang, Yuan; Wei, Qing; Wang, Zhen; Wan, Bin; Lv, Donglai; Li, Xiaofeng; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Li, Bihui; Zhang, Zhang; Wang, Ke; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Zhongwu; Li, Miao; Wang, Guansong; Wang, Jiandong; Fang, Meiyu; Fang, Yong; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Wang, Biyun; Si, Lu; Song, Yong; Lu, Yuanzhi; Liu, Aijun; Han, Yuchen

Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY study

腹泻与接受吡咯替尼治疗的 HER2 阳性晚期乳腺癌患者生存率之间的关联:来自真实世界 PRETTY 研究的里程碑式分析

Li, Yiqun; Wang, Wenna; Tong, Zhongsheng; Wu, Xinhong; Cai, Li; Ouyang, Quchang; Li, Wei; Yu, Zhiyong; Han, Zhengxiang; Wang, Xiaojia; Li, Man; Wang, Haibo; Li, Li; Yang, Jin; Xu, Binghe

Synergistic Anti-Tumor Activity of LRPPRC Inhibition and Dasatinib Through Dual Oxidative Phosphorylation Disruption

LRPPRC抑制剂与达沙替尼通过双重氧化磷酸化破坏发挥协同抗肿瘤活性

Chen, Jing; Gao, Lu; Liang, Yuxin; Zhou, Wei; Wang, Yong; Wang, Xiaojia; Fang, Xiaohong; Shao, Xiying

Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke: A Multicenter Prospective Cohort Study

静脉溶栓前后纤维蛋白原变化作为急性缺血性卒中脑损伤和临床结局的预测指标:一项多中心前瞻性队列研究

Zhai, Wenhai; Qu, Yang; Abuduxukuer, Reziya; Zhang, Kejia; Zhang, Peng; Tang, Xin; Zhang, Huaimei; Wang, Lijuan; Yang, Lichong; Tan, Shuangxu; Yuan, Zhimei; Han, Ce; He, Lili; Zheng, Yuping; Zhao, Fenglan; Guo, Lijie; Jiang, Ligang; Li, Jinfeng; Jiang, Yongfei; Zou, Xuexia; Xu, Dan; Xu, Han; Wang, Xiaojia; Qi, Yingbin; Hu, Xuefeng; Zhang, Yu; Guo, Zhen-Ni; Jin, Hang

Effect of Freckle Defects on Hot Deformation Behavior and Dynamic Recrystallization Structure Inheritance of an Iron-Nickel-Based Superalloy

斑点缺陷对铁镍基高温合金热变形行为和动态再结晶组织继承的影响

Zhang, Lianjie; Wang, Xiaojia; Wang, Yuhan; Wang, Lei; Duan, Ran; Huang, Shuo; Xu, Guohua; Liu, Yang

Integration of Single-cell and Bulk Transcriptome Analyses Unravels a Macrophage-based Gene Signature for Prognostication and Treatment in Triple-negative Breast Cancer

单细胞和批量转录组分析的整合揭示了基于巨噬细胞的基因特征,可用于三阴性乳腺癌的预后和治疗

Huang, Yuan; Yu, Yuan; Zhu, Yufei; Lu, Qianhui; Zhang, Ziwen; Wang, Xiaojia; Wang, Xiaowei; Zheng, Yabing

Chinese expert consensus on endocrine therapy for breast cancer (2026 edition)

中国乳腺癌内分泌治疗专家共识(2026版)

Yuan, Yang; Yin, Yongmei; Wang, Shu; Liu, Yueping; Yang, Jin; Yan, Min; Mo, Xueli; Pan, Yueyin; Wang, Xiaojia; Wang, Haibo; Li, Jianbin; Wang, Shusen; Wu, Jiong; Song, Erwei; Jiang, Zefei

International guidelines on the diagnosis and treatment of NUT carcinoma

关于NUT癌诊断和治疗的国际指南

Zhang, Yu; Zhang, Qi; Hao, Yue; Luo, Jia; Piao, Yingshi; Wang, Wenxian; Song, Zhengbo; Li, Ziming; Brcic, Luka; Liu, Aijun; Yu, Jinpu; Tsutani, Yasuhiro; Zhong, Wenzhao; Fang, Wenfeng; Wang, Zhijie; Ren, Shengxiang; Papavassiliou, Athanasios G; Zhang, Yongchang; Liu, Jingjing; Zhang, Shirong; Cai, Xiuyu; Cangir, Ayten Kayi; Liu, Anwen; Li, Wen; Lococo, Filippo; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Miao, Liyun; Min, Lingfeng; Popper, Helmut; Chen, Yu; Yuan, Jingping; Wang, Feng; Jiang, Zhansheng; Lin, Gen; Huang, Long; Pu, Xingxiang; Lin, Rongbo; Kairemo, Kalevi; Liu, Weifeng; Rao, Chuangzhou; Lv, Dongqing; Yu, Zongyang; Leanne, Ashrafian; Li, Xiaoyan; Tang, Chuanhao; Siddique, Hifzur R; Zhou, Chengzhi; Zhang, Junping; Xue, Junli; Shelat, Vishal; Guo, Hui; Chu, Qian; Meng, Rui; Ardeshir, Fatemeh; Wu, Jingxun; Zhang, Rui; Zhou, Jin; Kratzke, Robert A; Zhu, Zhengfei; Li, Yongheng; Qiu, Hong; Xia, Fan; Calabrese, Fiorella; Xia, Yang; Mariani, Alessandro Wasum; Lu, Yuanyuan; Chen, Xiaofeng; Klein, Mark A; Ge, Rui; Dai, Enyong; Schönthal, Axel H; Han, Yu; Guo, Zhenying; Zhang, Jian; Ji, Yinghua; Liang, Xianbin; Zhang, Hongmei; Ma, Xuelei; Chiappetta, Marco; Liu, Xuewen; Salle, Francoise Galateau; Yao, Yu; Szolkowska, Malgorzata; Pan, Weiwei; Pang, Fei; Wu, Fan; Watzka, Stefan B; Wang, Liping; Zhu, Youcai; Lin, Li; Sharma, Aparna; Tu, Jianfei; Lin, Xinqing; Cai, Jing; Xu, Ling; Li, Jisheng; Jiao, Xiaodong; Li, Kainan; Zauderer, Marjorie G; Wei, Jia; Feng, Huijing; Wang, Lin; Du, Yingying; Yao, Wang; Dudnik, Elizabeth; Shi, Xuefei; Niu, Xiaomin; Yuan, Dongmei; Yao, Yanwen; Huang, Jianhui; Feng, Yue; Zhang, Yinbin; Song, Binbin; Li, Wenfeng; Fu, Jianfei; Baine, Marina K; Sun, Pingli; Wang, Hong; Ye, Mingxiang; Wang, Dong; Wang, Zhaofeng; Wu, Jing; Yang, Yunyun; Fang, Yuan; Wang, Zhen; Wan, Bin; Lv, Donglai; Chen, Huafei; Yang, Shengjie; Kang, Jing; Zhang, Jiatao; Zhang, Chao; Shi, Lin; Wang, Yina; Sobeih, Mohamed Emam; Li, Bihui; Lian, Bin; Mao, Lili; Zhang, Zhang; Wang, Ke; Li, Zhongwu; Liu, Zhefeng; Yang, Nong; Wu, Lin; Chen, Xiaobing; Jin, Gu; Li, Miao; Wang, Guansong; Marron, Thomas U; Wang, Jiandong; Popat, Sanjay; Fang, Meiyu; Fang, Yong; Mansilla, Daniel; Li, Yuan; Wang, Xiaojia; Chen, Jing; Zhang, Yiping; Zhu, Xixu; Shen, Yi; Ma, Shenglin; Mansfield, Aaron S; Wang, Biyun; Si, Lu; Roden, Anja C; Grønberg, Bjørn H; Song, Yong; Shapiro, Geoffrey I; French, Christopher A; Lu, Yuanzhi; Wang, Qian; Xu, Chunwei

Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial

新型 CDK2/4/6 抑制剂 culmerciclib (TQB3616) 联合氟维司群治疗既往接受过治疗的 HR 阳性、HER2 阴性晚期乳腺癌:一项随机、双盲、3 期试验

Yin, Yongmei; Zhang, Qingyuan; Sun, Tao; Hao, Chunfang; Wang, Zhihong; Yang, Jin; Wang, Yongsheng; Shi, Yanxia; Sun, Jing; Ouyang, Quchang; Su, Haichuan; Wu, Jinsheng; Gan, Lu; Han, Meng; Gao, Liming; Wang, Xiaojia; Zhao, Bing; Li, Hui; Zhao, Jiuda; Yang, Hongwei; Ning, Fangling; Tian, Fuguo; Zhang, Juliang; Sun, Hongmei; Niu, Zhaofeng; Zong, Hong; Zang, Aimin; Wang, Xinshuai; Qian, Xinyu; Wu, Shikai; Nie, Jianyun; He, Lijia; Cheng, Ying; Hao, Yanrong; Zhai, Yi; Li, Huiping; Wang, Jingfen; Wei, Shihong; Li, Man; Liu, Yunjiang; Guo, Hongqiang; Hu, Qun; Liu, Lina; Han, Xinghua; Luo, Ruizhen; Ni, Mingli; Tang, Xianjun; Zhai, Zhenhua; Ding, Meiqian; Wang, Haibo; Shen, Peng; Wang, Xian; Liu, Lian; Chen, Wenyan; Liu, Gang; Cai, Zhengwen; Jiang, Zefei